Steroid management in newly diagnosed glioblastoma

Journal of Neuro-Oncology

Volumn 113, Issue 1, 2013, Pages 111-116

  Deutsch, Mariel B ^a   Panageas, Katherine S ^a   Lassman, Andrew B ^a   Deangelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Corticosteroid; Dosage; Glioma; Glucocorticoid; Radiotherapy

Indexed keywords

STEROID; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FEMALE; FUNCTIONAL STATUS; GLIOBLASTOMA; HEADACHE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84876911852     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1096-4     Document Type: Article

References (18)

1. DeAngelis LM (1994) Management of brain metastases. Cancer Invest 12:156-165
2. Koehler PJ (1995) Use of corticosteroids in neuro-oncology. Anticancer Drugs 6:19-33
3. Nahaczewski AE, Fowler SB, Hariharan S (2004) Dexamethasone therapy in patients with brain tumors-a focus on tapering. J Neurosci Nurs 36:340-343
4. Richter B, Neises G, Clar C (2002) Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinol Metab Clin North Am 31:751-758
5. Stummer W (2007) Mechanisms of tumor-related brain edema. Neurosurg Focus 22:E8
6. Hopkins RL, Leinung MC (2005) Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 34:371-384
7. Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE (2009) Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. J Clin Oncol 27:3861-3867
8. Hohwieler Schloss M, Freidberg SR, Heatley GJ, Lo TC (1989) Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas. Acta Oncol 28:51-55
9. Watne K, Hannisdal E, Nome O, Hager B, Hirschberg H (1993) Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy. Acta Oncol 32:307-310
10. Gundersen S, Lote K, Hannisdal E (1996) Prognostic factors for glioblastoma multiforme-development of a prognostic index. Acta Oncol 35(Suppl 8):123-127
11. Gelblum DY, Lee H, Bilsky M, Pinola C, Longford S, Wallner K (1998) Radiographic findings and morbidity in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 42:391-395
12. Ryan R, Booth S, Price S (2012) Corticosteroid-use in primary and secondary brain tumour patients: a review. J Neurooncol 106:449-459
13. Pruitt AA (2011) Medical management of patients with brain tumors. Curr Treat Options Neurol 13:413-426
14. Sturdza A, Millar BA, Bana N, Laperriere N, Pond G, Wong RK, Bezjak A (2008) The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer 16:1041-1048
15. Wissinger JP, French LA, Gillingham FJ (1967) The use of dexamethasone in the control of cerebral oedema. J Neurol Neurosurg Psychiatry 30:588
16. Vecht CJ, Hovestadt A, Verbiest HB, van Vliet JJ, van Putten WL (1994) Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 44:675-680
17. Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Kalkanis SN (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103-114
18. Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA et al (1991) Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. J Neurooncol 11:235-239